Sage Capital Advisors,Llc Abb Vie Inc. Transaction History

Sage Capital Advisors,Llc

$374 Million
Q3 2024

A detailed history of Sage Capital Advisors,Llc transactions in Abb Vie Inc. stock. As of the latest transaction made, Sage Capital Advisors,Llc holds 22,455 shares of ABBV stock, worth $4.57 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

22,455

Previous 19,243 16.69%

Holding current value

$4.57 Million

Previous $3.3 Million 34.36%

% of portfolio

1.19%

Previous 0.96%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$163.84 - $199.33 $526,254 - $640,247	3,212 Added 16.69%	22,455 $4.43 Million
Q2 2024 Jul 09, 2024	BUY	$154.79 - $180.76 $51,390 - $60,012	332 Added 1.76%	19,243 $3.3 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $7,831 - $8,922	49 Added 0.26%	18,911 $3.44 Million
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $43,894 - $49,435	319 Added 1.72%	18,862 $2.92 Million
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $62,653 - $72,530	469 Added 2.59%	18,543 $2.76 Million
Q2 2023 Jul 12, 2023	BUY	$132.51 - $164.9 $273,368 - $340,188	2,063 Added 12.88%	18,074 $2.44 Million
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $40,924 - $47,130	283 Added 1.8%	16,011 $2.55 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $4,979 - $5,971	-36 Reduced 0.23%	15,728 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $119,446 - $136,997	-890 Reduced 5.34%	15,764 $2.12 Million
Q2 2022 Jul 06, 2022	SELL	$137.62 - $174.96 $688 - $874	-5 Reduced 0.03%	16,654 $2.55 Million
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $3.56 Million - $4.41 Million	-26,961 Reduced 61.81%	16,659 $2.92 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $288,127 - $364,564	2,682 Added 6.55%	43,620 $5.9 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $49,050 - $55,679	461 Added 1.14%	40,938 $4.42 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $304,056 - $338,736	2,890 Added 7.69%	40,477 $4.74 Million
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $2,762 - $3,040	-27 Reduced 0.07%	37,587 $4.07 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $5,392 - $7,280	67 Added 0.18%	37,614 $4.08 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $1.31 Million - $1.54 Million	15,279 Added 68.61%	37,547 $3.29 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $293 - $392	4 Added 0.02%	22,268 $2.19 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $1.11 Million - $1.68 Million	17,182 Added 338.1%	22,264 $1.7 Million
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $154 - $181	2 Added 0.04%	5,082 $410,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $395,478 - $487,730	5,080 New	5,080 $468,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.6 Million - $1.78 Million	-18,009 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.62 Million - $1.91 Million	18,009 New	18,009 $1.67 Million

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Account

Sage Capital Advisors,Llc Abb Vie Inc. Transaction History